​Meaning 

---

“The Global Cell and Gene Therapy Market is estimated to be worth between £10 to £40 Billion by 2025”

The Annual Cell and Gene Therapy Innovation Summit is the only executive gathering committed to creating an advanced networking platform to increase innovation and collaboration within the Cell & Gene Therapy area.
​
Our cutting-edge programme covers critical subjects such as progress cell gene therapy manufacturing, ATMP development, scale-up and scale-out, manufacturing data, R&D, CART therapies, global regulatory affairs, stem cells, cord blood, pricing & reimbursement, improving cost efficiency, commercialization, as well how to leverage innovation to convert cutting-edge research to advance cell gene therapy manufacturing.

​Audience

---

Join up to 200 Decision Makers and attend the Exclusive CGTI Leaders Summit, benchmarking with Director-level and above leaders from areas such as:

• Cell Therapy Research
• Manufacturing Innovation
• Global Medical Affairs
• CMC
• Regulatory Affairs
• Regenerative Medicine
• Advanced Therapy Production
• Gene Therapy Development
• Clinical Platform Development
• Cellular Therapy Immuno-Oncology
• Manufacturing and R&D
• Quality Control
• GMP
• Cell & Tissue Therapy
• Global Pricing and Market Access

​Speakers

---

Jean-Pierre Latere COO - Celyad SA

Ohad Karnieli CEO ATVIO Biotech Ltd.

Ajan Reginald CEO - Celixir

Sandra van Wetering - COO DCPrime

Lior Raviv - VPD Pluristem Therapeutics

Stefan Glück - GVP MA Celgene Corporation

---

Themes and Topics

---

• Perspectives on adjustments and Bio-Quality of Cell & Gene Therapy Bioprocessing
• Future Enhancements of Manufacturing Technologies 
• Identify the Opportunities and Challenges in Advanced Therapy Manufacturing Process 
• Regulatory insight on ATMP Development
• Leveraging Innovation to convert cutting-edge research to advance cell gene therapy manufacturing and processes
• Cell, Gene and Immunotherapy Manufacturing
• Automation and Cold Chain
• Cell, Gene and Immunotherapy USP, DSP, PAT and Analytics 
• Emerging Cell Therapy Treatments 
• Analytical Testing and Quality Systems 

Series Attendee Quotes

---

• Great people, new technology and great views for the future - Sanofi Pasteur

• Good diverse topics discussed, a bird's eye view across bioprocessing is valuable - Bayer

   

• Loved it. Thank you, good work! Excellent place to meet decision makers and active innovators - Chromatan

 

• Conducive environment for direct interaction. Personalized for building business relationships. Great networking, great size - Asahi Kasei

​

• Nicely organized. Relevant topics which provide insights on lessons learned - Sutro Biopharma

Sponsor Spotlight

---

Media Partners

---

---

Summit Highlights

---

---

Join the Conversation

---

Christian van den Bos - Managing Director

Jean-Pierre Latere - COO

Shirley Bartido - Director of Regulatory Affairs

Martin Pohle - Branch Manager Pharmaceutical & Specialty Logistics

Tweets by bioprocessWorld